Cost Utility of Vaccination Against COVID-19 in Brazil
- 21 March 2022
- journal article
- research article
- Published by Elsevier in Value in Health Regional Issues
- Vol. 31, 18-24
Abstract
No abstract availableKeywords
Funding Information
- Federal Government of Brazil
This publication has 14 references indexed in Scilit:
- Novel coronavirus 2019 (COVID-19) pandemic outbreak: A comprehensive review of the current literatureVacunas, 2021
- Demographic, clinical, laboratory, and genetic risk factors associated with COVID-19 severity in adults: A narrative reviewDental and Medical Problems, 2021
- Effectiveness of BNT162b2 mRNA Vaccine Against Infection and COVID-19 Vaccine Coverage in Healthcare Workers in England, Multicentre Prospective Cohort Study (the SIREN Study)SSRN Electronic Journal, 2021
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UKThe Lancet, 2021
- COVID-19 hospitalizations in Brazil’s Unified Health System (SUS)PLOS ONE, 2020
- The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global statusJournal of Infection and Public Health, 2020
- Risk Factors for Hospitalization and Mortality due to COVID-19 in Espírito Santo State, BrazilThe American Journal of Tropical Medicine and Hygiene, 2020
- Epidemiologic and clinical features of patients with COVID-19 in BrazilEinstein (São Paulo), 2020
- Outcomes for Patients With COVID-19 and Acute Kidney Injury: A Systematic Review and Meta-AnalysisKidney International Reports, 2020
- Postdischarge symptoms and rehabilitation needs in survivors of COVID‐19 infection: A cross‐sectional evaluationJournal of Medical Virology, 2020